Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is ...

VERSATILE-003 Phase 3 Site Initiations Underway Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting Conference call and webcast today at 8:00 ...

Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...

Nabla Bio's latest AI model update generates de novo antibodies for GPCRs with therapeutic-grade properties within a few ...

Operator: Good afternoon, and welcome to Oncolytics Biotech First Quarter Conference Call. All participants are in a listen-only mode.

Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a ...

A new study published in Aging Cell demonstrates that artificial intelligence can be used not just to accelerate drug ...

Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...

Whether you’re working in a startup, academic lab, or biopharma R&D team, this eBook offers a window into what’s working now and what’s possible next.

Rituricha Jain is reimagining paper production with Paperdom, crafting sustainable, 100% tree-free paper from banana fibre ...

The trial, which will involve sites in the U.S., Europe, and the Middle East, aims to combine Phase 2B and Phase 3 data for ...